Anteris Technologies
Chris Brodeur is a highly experienced engineering professional with a robust background in biomedical device development and testing. As the Lead Principal Engineer at Anteris Technologies since February 2021, Chris has consistently demonstrated expertise in managing complex testing environments and training junior engineers. Prior roles include Sr. Principal R&D Engineer at Neovasc Inc. and Principal R&D Engineer at HLT, Inc., where Chris oversaw extensive valve testing programs and mentored technical staff. Chris's earlier experience includes significant contributions to catheter-based products and implantable devices at various companies, including American Medical Systems, Teleflex Medical, and Boston Scientific. Chris holds a B.S. in Physics from the University of California, Riverside.
Anteris Technologies
1 followers
Anteris Technologies is a structural heart company focused on developing innovative solutions to the biggest challenges facing aortic stenosis patients and their physicians. Our DurAVR™ Transcatheter Heart Valve (THV) System is designed for younger patients who need a heart valve that will last their lifetime. DurAVR™ THV is a unique, single-piece valve and its first-in-class biomimetic design replicates the normal blood flow of a healthy human aortic valve. | $AVR | ASX: AVR | #DurAVR #ADAPT #structuralheart #TAVR #TAVI #cardiology